BPR1M97 is a dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor agonist with K i values of 1.8 and 4.2 nM, respectively. BPR1M97 shows high potency and blood-brain barrier penetration, and produces potent antinociceptive effectsIn VivoBPR1M97 (1.8 mg/kg; s.c.; once) demonstrates antinociception in a murine model of cancer pain . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male wild-type C57BL/6 mice (25-30 g) Dosage: 1.8 mg/kg Administration: Subcutaneous injection (s.c.); once Result: Demonstrated antinociception in a murine model of cancer pain.Form:SolidIC50& Target:Ki: 1.8 nM (MOP), 4.2 nM (NOP). Specification: 0.98 Molecular Formula: C18H18Cl2N2O Molecular Weight: 349.25
- UPC:
- 12352005
- Condition:
- New
- Availability:
- 8-12 weeks
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- B649305-50mg
- CAS:
- 2059904-66-2
- Product Size:
- 50mg
